These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 2869764)
21. Pharmacological profile of nicardipine hydrochloride in anesthetized dogs with acute heart failure. Part 1: Hemodynamic effects in normal dogs and dogs with acute heart failure. Saitoh C; Momose K; Tanaka H; Sato S; Taguchi K; Saitoh M; Maehara J; Asano M; Usuda S Arzneimittelforschung; 1998 Feb; 48(2):125-32. PubMed ID: 9541721 [TBL] [Abstract][Full Text] [Related]
22. Antihypertensive actions of an isomer of labetalol and other vasodilator-beta-adrenoceptor blockers. Baum T; Sybertz EJ Fed Proc; 1983 Feb; 42(2):176-81. PubMed ID: 6130003 [TBL] [Abstract][Full Text] [Related]
23. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol. Lund-Johansen P Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890 [TBL] [Abstract][Full Text] [Related]
24. [Effects of labetalol on the circulatory system (author's transl)]. Monma Y; Okuoka Y; Kameda H; Ichihara K; Abiko Y; Tanabe T Nihon Yakurigaku Zasshi; 1980 May; 76(4):239-54. PubMed ID: 6108907 [TBL] [Abstract][Full Text] [Related]
25. [Effects of phenolic alkaloids of Menispermum dauricum on the hemodynamics and coronary circulation in anesthetized dog]. Li YQ; Yang XY; Zhou SC; Gong PL Yao Xue Xue Bao; 2003 Sep; 38(9):658-60. PubMed ID: 14730913 [TBL] [Abstract][Full Text] [Related]
26. Partial agonist activity of celiprolol as assessed in conscious unrestrained dogs in comparison with those of pindolol and labetalol. Ishibashi T; Ohta H; Jin H; Mitomi A; Tatebe S; Nakazawa M; Imai S Arzneimittelforschung; 1989 Oct; 39(10):1225-8. PubMed ID: 2575385 [TBL] [Abstract][Full Text] [Related]
27. Pharmacological profile of a new beta-adrenoceptor blocker, 4-[3-(tert-butylamino)-2-hydroxypropoxy]-N-methylisocarbostyril hydrochloride (N-696). Nakagawa Y; Sugai T; Chin WP; Shibuya T; Hashimoto K; Imai S Arzneimittelforschung; 1984; 34(2):194-9. PubMed ID: 6144313 [TBL] [Abstract][Full Text] [Related]
28. Coronary and systemic hemodynamic effects of diazepam (Valium) in the unanesthetized dog. Bloor CM; Leon AS; Walker DE Res Commun Chem Pathol Pharmacol; 1973 Nov; 6(3):1043-51. PubMed ID: 4760879 [No Abstract] [Full Text] [Related]
29. Hemodynamic profile of N-(2,5-dimethyl-1H-pyrrol-1-yl)6-(4-morpholinyl)-3-pyridazinamine hydrochloride in conscious dogs. Di Francesco GF; Baldoli E; Marchetti G; Glässer A Arzneimittelforschung; 1986; 36(1):84-8. PubMed ID: 3954821 [TBL] [Abstract][Full Text] [Related]
30. Systemic and coronary hemodynamic effects of pinacidil, a new antihypertensive agent, in awake dogs: comparison with hydralazine. Kawashima S; Liang CS J Pharmacol Exp Ther; 1985 Feb; 232(2):369-75. PubMed ID: 3968638 [TBL] [Abstract][Full Text] [Related]
31. Cardiovascular profile of RWJ 29009, a new potassium channel activator, in anesthetized and conscious dogs. Damiano BP; Giardino EC; Haertlein BJ; Stump GL; Mitchell JA; Falotico R J Cardiovasc Pharmacol; 1994 Feb; 23(2):300-10. PubMed ID: 7511761 [TBL] [Abstract][Full Text] [Related]
32. Adrenoceptor blocking hemodynamic and coronary effects of YM-09538, a new combined alpha- and beta-adrenoceptor blocking drug, in anesthetized dogs. Takenaka T; Asano M; Berdeaux A; Giudicelli JF Eur J Pharmacol; 1982 Nov; 85(1):35-50. PubMed ID: 6129981 [TBL] [Abstract][Full Text] [Related]
33. Effects of indomethacin and etodolac on coronary blood flow and other cardiovascular variables in propranolol-treated dogs. Beaulieu G Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):283-90. PubMed ID: 3161477 [TBL] [Abstract][Full Text] [Related]
34. Acute effect of hydralazine administration on pulmonary artery hemodynamics in dogs with chronic heartworm disease. Atkins CE; Keene BW; McGuirk SM; Sato T Am J Vet Res; 1994 Feb; 55(2):262-9. PubMed ID: 8172418 [TBL] [Abstract][Full Text] [Related]
35. Effects of papaveroline-monosulphate on the systemic and regional circulation in the dog. Data PG; Rolfo A; Cacchio M; Di Tano G Farmaco Sci; 1981 Apr; 36(4):302-14. PubMed ID: 7250364 [TBL] [Abstract][Full Text] [Related]
36. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046. Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223 [TBL] [Abstract][Full Text] [Related]
37. The inotropic and beta blocking effects of a chimeric molecule that putatively inhibits both type III phosphodiesterase and beta adrenoceptors in anesthetized dogs. Shaffer JE; Grizzle MK; Anderson DK; Wheeler TN J Pharmacol Exp Ther; 1993 Jun; 265(3):1105-12. PubMed ID: 8099617 [TBL] [Abstract][Full Text] [Related]
38. [Hemodynamic effects of medroxalol in the anesthetized dog. Relation between adrenolytic properties and plasma concentration]. Weissenburger J; Heckle J; Juliard JM; Biour M; Haegele K; Cheymol G J Pharmacol; 1983; 14(4):413-23. PubMed ID: 6142982 [TBL] [Abstract][Full Text] [Related]
40. Glucagon: its mechanism of action on the coronary circulation in the conscious dog. Terry B; White FC; Bloor CM Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):383-9. PubMed ID: 5074531 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]